Claims
- 1. An orally administered composition comprising hyaluronic acid having a dosage of between 35 to 45 mg and a low molecular weight of between 50,000 to 200,000 daltons.
- 2. A method for skin softening, comprising oral administration of hyaluronic acid in the form of a soft gelatin capsule having a dosage of between about 35 to about 45 mg and a molecular weight between 50,000 and 200,000 daltons, wherein the dosage of hyaluronic acid is derived from an extract containing about 9% hyaluronic acid.
- 3. The method of claim 2, wherein the soft gelatin capsule further includes beeswax.
- 4. The method of claim 2, wherein the soft gelatin capsule further includes rice bran oil.
- 5. The method of claim 2, wherein the soft gelatin capsule further includes beeswax and rice bran oil.
- 6. A method for skin softening, comprising oral administration of hyaluronic acid in the form of a soft gelatin capsule having a dosage of between about 35 to about 45 mg and a molecular weight between 50,000 and 200,000 daltons, wherein the hyaluronic acid is derived from the combs of roosters.
- 7. The method of claim 6, wherein the soft gelatin capsule further includes beeswax.
- 8. The method of claim 6, wherein the soft gelatin capsule further includes rice bran oil.
- 9. The method of claim 6, wherein the soft gelatin capsule further includes beeswax and rice bran oil.
CROSS REFERENCE TO RELATED APPLICATION
[0001] This application is a continuation of and claims priority to U.S. application Ser. No. 10/035,753, filed Dec. 21, 2001, the contents of which are incorporated herein by reference.
Continuations (1)
|
Number |
Date |
Country |
Parent |
10035753 |
Dec 2001 |
US |
Child |
10887066 |
Jul 2004 |
US |